Thoracic Limb Osteosarcoma in a Dog: Treatment with Endo-Exo-Prosthesis
DOI:
https://doi.org/10.22456/1679-9216.148642Keywords:
bone neoplasm, limb amputation, prosthesis, chemotherapyAbstract
Background: Osteosarcoma (OSA) is the most common primary malignant bone tumor in dogs, accounting for approximately 85% of all malignant bone neoplasms. It primarily affects large-breed and older dogs, with the appendicular skeleton being the most affected site. The disease has an aggressive course, a high metastatic rate, and usually a poor prognosis. Treatment generally involves surgery and chemotherapy, with limb amputation being the traditional procedure. The study aims to report the case of a Saint Bernard dog with OSA in the distal region of the radius and ulna, treated with surgical partial limb amputation and implantation of an endo-exo-prosthesis, and adjuvant chemotherapy.
Case: A 9-year-old, intact male Saint Bernard dog, weighing 65 kg, was admitted to the University Veterinary Hospital with a history of swelling in the distal region of radius and ulna of the left thoracic limb. Radiographic and histopathological evaluation confirmed a diagnosis of osteosarcoma (OSA), and staging examinations showed no evidence of pulmonary metastases. The treatment included partial limb amputation at the mid-third of the radius and ulna followed by implantation of a custom-made titanium endo-exo-prosthesis, and adjunctive chemotherapy. The surgical procedure involved osteotomy of the radius and ulna, intramedullary canal reaming for implant accommodation, and manual implantation of the endo-exo-prosthesis. Immediate postoperative radiographic assessment indicated proper implant positioning. Five days after surgery, soft tissue retraction and suture dehiscence occurred, leading to bone exposure and requiring soft tissue reapproximation at the base of the prosthesis. After 20 days of hospitalization, the patient was discharged with incomplete healing at the skin-implant interface, requiring continuous home wound care. Upon returning 45 days after surgical procedure, the patient showed signs of implant infection. Radiographic examination revealed peri-implant bone resorption and irregular bone proliferation. Bacterial culture identified Klebsiella pneumoniae strain, sensitive to meropenem. After completion of antibiotic therapy, a subsequent culture identified a multidrug-resistant Acinetobacter sp. infection. Given the ongoing infection and progressive peri-implant bone resorption and implant failure, limb amputation was performed approximately three months after prosthesis implantation. Approximately 6 months after the OSA diagnosis, the patient was hospitalized with severe dyspnea. Thoracic radiography revealed the presence of pulmonary metastases, and euthanasia was performed.
Discussion: The use of endo-exo-prosthesis in dogs presents significant challenges, particularly concerning the soft tissue–implant interface and osseointegration. Successful adaptation of the skin and musculature to the prosthesis is critical for long-term outcomes, as failures at this interface can lead to complications such as infection, dehiscence, and implant failure. Canine patients pose additional difficulties due to factors such as the presence of fur, considerable variability in limb anatomy and size, challenges in enforcing activity restriction, and the potential for secondary issues caused by licking behavior. The reported case highlights both the potential benefits and challenges of endo-exo-prostheses in the treatment of canine OSA. Although the procedure initially preserved limb functionality, postoperative complications, such as soft tissue retraction, infection, and issues with osteointegration, resulted in prosthetic implant failure. The need for improved surgical techniques and the development of technologies that enhance osteointegration and healing at the skin-implant interface is emphasized, aiming to reduce complication rates and improve patient outcomes.
Keywords: bone neoplasm, limb amputation, prosthesis, chemotherapy.
Título: Osteossarcoma de membro torácico em um cão: tratamento com endo-exo-prótese
Descritores: neoplasia óssea, amputação de membro, prótese, quimioterapia.
Downloads
References
1 Aschoff H.H., Kennon R.E., Keggi J.M. & Rubin L.E. 2010. Transcutaneous, distal femoral, intramedullary attachment for above-the-knee prostheses: an endo-exo device. The Journal of Bone and Joint Surgery. 92(2): 180-186. DOI: 10.2106/JBJS.J.00806.
2 Branemark P.I. 1959. Vital microscopy of bone marrow in rabbit. Scandinavian Journal of Clinical and Laboratory Investigation. 11(38): 1-82.
3 Bryan J.N. 2024. Updates in osteosarcoma. The Veterinary Clinics of North America. Small Animal Practice. 54(3): 523-539. DOI: 10.1016/j.cvsm.2023.12.007
4 Carli A., Gao C., Khayyat-Kholghi M., Li A., Wang H., Ladel C., Harvey E.J. & Henderson J.E. 2012. FGF18 augments osseointegration of intra-medullary implants in osteopenic FGFR3(-/-) mice. European Cells & Materials. 24: 107-117. DOI: 10.22203/ecm.v024a08
5 Chun R. 2005. Common malignant musculoskeletal neoplasms of dogs and cats. The Veterinary Clinics of North America. Small Animal Practice. 35(5): 1155-1167. DOI: 10.1016/j.cvsm.2005.05.00
6 Compston J.E. 2001. Sex steroids and bone. Physiological Reviews. 81(1): 419-447. DOI: 10.1152/physrev.2001.81.1.419.
7 Dernell W.S. 2007. Tumors of the skeletal system. In: Withrow & MacEwen (Eds). Small Animal Clinical Oncology. Saint Louis: Elsevier, pp.540-582.
8 Drygas K.A., Taylor R., Sidebotham C.G., Hugate R.R. & McAlexander H. 2008. Transcutaneous tibial implants: a surgical procedure for restoring ambulation after amputation of the distal aspect of the tibia in a dog. Veterinary Surgery. 37(4): 322-327. DOI: 10.1111/j.1532-950X.2008.00384.x
9 Edmunds G.L., Smalley M.J., Beck S., Errington R.J., Gould S., Winter H., Brodbelt D.C. & O’Neill D.G. 2021. Dog breeds and body conformations with predisposition to osteosarcoma in the UK: a case-control study. Canine Medicine and Genetics. 8(1): 2. DOI: 10.1186/s40575-021-00100-7
10 Fink A., Malak A., Al Muderis M., Lu W. & Levien A.S. 2025. Use of a tibial osseointegrated prosthesis as a limb salvage method in two dogs. Australian Veterinary Journal. 103(6): 368-376. DOI: 10.1111/avj.13438
11 Fitzpatrick N., Smith T.J., Pendegrass C.J., Yeadon R., Ring M., Goodship A.E. & Blunn G.W. 2011. Intraosseous transcutaneous amputation prosthesis (ITAP) for limb salvage in 4 dogs: Intraosseous transcutaneous amputation prosthesis. Veterinary Surgery. 40(8): 909-925. DOI: 10.1111/j.1532-950X.2011.00891.x
12 Gordon D.J., Bhagawati D.D., Pendegrass C.J., Middleton C.A. & Blunn G.W. 2010. Modification of titanium alloy surfaces for percutaneous implants by covalently attaching laminin. Journal of Biomedical Materials Research. Part A. 94(2): 586-593. DOI: 10.1002/jbm.a.32735
13 Grüntzig K., Graf R., Boo G., Guscetti F., Hässig M., Axhausen K.W., Fabrikant S., Welle M., Meier D., Folkers G. & Pospischil A. 2016. Swiss Canine Cancer Registry 1955-2008: Occurrence of the most common tumour diagnoses and influence of age, breed, body size, sex and neutering status on tumour development. Journal of Comparative Pathology. 155(2-3): 156-170. DOI: 10.1016/j.jcpa.2016.05.011
14 Hagberg K. & Brånemark R. 2009. One hundred patients treated with osseointegrated transfemoral amputation prostheses-rehabilitation perspective. Journal of Rehabilitation Research and Development. 4(3): 331-344.
15 Hunziker E.B., Enggist L., Küffer A., Buser D. & Liu Y. 2012. Osseointegration: the slow delivery of BMP-2 enhances osteoinductivity. Bone. 51(1): 98-106. DOI: 10.1016/j.bone.2012.04.004
16 Jeyapalina S., Beck J.P., Agarwal J. & Bachus K.N. 2017. A 24-month evaluation of a percutaneous osseointegrated limb-skin interface in an ovine amputation model. Journal of Materials Science: Materials in Medicine. 28(11): 179. DOI: 10.1007/s10856-017-5980-x
17 Leonardo L., Laura P. & Serena B.M. 2018. miR-1 and miR-133b expression in canine osteosarcoma. Research in Veterinary Science. 117: 133-137. DOI: /10.1016/j.rvsc.2017.12.002
18 Liptak J.M., Dernell W.S., Ehrhart N., Lafferty M.H., Monteith G.J. & Withrow S.J. 2006. Cortical allograft and endoprosthesis for limb-sparing surgery in dogs with distal radial osteosarcoma: a prospective clinical comparison of two different limb-sparing techniques. Veterinary Surgery. 35(6): 518-533. DOI: 10.1111/j.1532-950X.2006.00185.x
19 Morello E., Martano M. & Buracco P. 2011. Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma. Veterinary Journal. 189(3): 268-277. DOI: 10.1016/j.tvjl.2010.08.014
20 Pendegrass C.J., El-Husseiny M. & Blunn G.W. 2012. The development of fibronectin-functionalised hydroxyapatite coatings to improve dermal fibroblast attachment in vitro. The Journal of Bone and Joint Surgery. 94(4): 564-569. DOI: 10.1302/0301-620X.94B4.27698
21 Pendegrass C.J., Goodship A.E. & Blunn G.W. 2006. Development of a soft tissue seal around bone-anchored transcutaneous amputation prostheses. Biomaterials. 27(23): 4183-4191. DOI: 10.1016/j.biomaterials.2006.03.041
22 Pitkin M. 2013. Design features of implants for direct skeletal attachment of limb prostheses. Journal of Biomedical Materials Research. Part A. 101(11): 3339-3348. DOI: 10.1002/jbm.a.34606
23 Thalji G., Gretzer C. & Cooper L.F. 2013. Comparative molecular assessment of early osseointegration in implant-adherent cells. Bone. 52(1): 444–453. DOI: 10.1016/j.bone.2012.07.026
24 Thompson K.G. & Dittmer K.E. 2016. Tumors of Bone. In: Meuten D.J. (Ed). Tumors in Domestic Animals. 5th edn. Ames: John Wiley & Sons Inc., pp.356-424.
25 Tuohy J.L., Shaevitz M.H., Garrett L.D., Ruple A. & Selmic L.E. 2019. Demographic characteristics, site and phylogenetic distribution of dogs with appendicular osteosarcoma: 744 dogs (2000-2015). PloS One. 14. DOI: 10.1371/journal.pone.0223243
26 Vail D.M., Thamm D.H. & Liptak J.M. 2019. Withrow & MacEwen (Eds). Small Animal Clinical Oncology. Saint Louis: Elsevier, pp.404-431.
27 Xiao D., Lu Y., Zhu L., Liang T., Wang Z., Ren J., He R. & Wang K. 2020. Anti-osteosarcoma property of decorin-modified titanium surface: A novel strategy to inhibit oncogenic potential of osteosarcoma cells. Biomedecine & Pharmacotherapie. 125 (110034). DOI: 10.1016/j.biopha.2020.110034
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Iara Araujo, Leonardo Augusto Lopes Muzzi, Daniel Munhoz, Raquel Athanasio, Luana Costa Mancilha Dias, Mariana Pimenta Neves, Lucas de Souza Pereira, Ivy Meira Liberato

This work is licensed under a Creative Commons Attribution 4.0 International License.
This journal provides open access to all of its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Such access is associated with increased readership and increased citation of an author's work. For more information on this approach, see the Public Knowledge Project and Directory of Open Access Journals.
We define open access journals as journals that use a funding model that does not charge readers or their institutions for access. From the BOAI definition of "open access" we take the right of users to "read, download, copy, distribute, print, search, or link to the full texts of these articles" as mandatory for a journal to be included in the directory.
La Red y Portal Iberoamericano de Revistas Científicas de Veterinaria de Libre Acceso reúne a las principales publicaciones científicas editadas en España, Portugal, Latino América y otros países del ámbito latino